BAUM CHARLES M - Insider Non-Derivative Transactions at Mirati Therapeutics, Inc. (MRTX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 23, 2024, BAUM CHARLES M's relationship to Mirati Therapeutics, Inc. (MRTX) is Director,Officer (Founder, President, and CEO), and currently has 114,482 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other MRTX insiders.

Data Source: SEC.
BAUM CHARLES M - Insider Non-Derivative Transactions of MRTX Common Stock
BAUM CHARLES M - Insider Non-Derivative Transactions at MRTX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jan 24, 2024 Disposition -- (Common Stock) 20425 0 0
Jan 24, 2024 Disposition -- (Common Stock) 94057 0 20425
Jan 24, 2024 Disposition -- (Common Stock) 123389 0 114482
Dec 30, 2023 Acquisition -- (Common Stock) 20425 58.75 247700
Aug 10, 2023 Acquisition -- (Common Stock) 54054 37 227275
Jan 21, 2023 Acquisition -- (Common Stock) 4444 0 173221
Jan 5, 2023 Sell -- (Common Stock) 3648 46.6 168777